Cat. No.: DIA-0230576
Product Information | |
---|---|
CAS No. | 54-36-4 |
Synonyms | 2-methyl-1,2-di-3-pyridyl-1-propanone, 2-methyl-1,2-dipyridin-3-ylpropan-1-one, |
Formula | C14H14N2O |
Molecular Weight | 226.27 |
SMILES | CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2 |
Target | Cytochrome P450-mediated ω/ω-1 hydroxylase/CYP11B1. |
Product Description | Metyrapone is an inhibitor of cytochrome P450-mediated ω/ω-1 hydroxylase activity and CYP11B1. |
Format & Storage | |
---|---|
Purity | > 99% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.